Page 162 - JSOM Summer 2022
P. 162

Overall, the data both in hospital and prehospital/operational   Ahern et al. noted that 18 out of 500 patients receiving low
          settings supports the current dosing strategy of low dose ket-  dose ketamine (LDK) (3.5%) had psychomimetic or dysphoric
          amine (LDK). Based upon a study finding that the weight of   reactions, however, only 3 required a benzodiazepine. The
                                                  44
          the average service member as of 2016 is 76.7 kg.  and the   authors of that study concluded that the “use of LDK as an
          presumption of combat injury patterns requiring high doses of   analgesic in a diverse ED patient population appears to be
                                                                                                            92
          analgesia, the CoTCCC recommends an initial ketamine dose   safe and feasible for the treatment of many types of pain.”
          of 20–30mg. The 30mg dose corresponds to 0.39mg/kg for   Elsewhere, Sin’s review of four studies (n = 428) using LDK
          a 76.7-kg patient (the upper limit of the 0.1–0.4mg/kg non-  ranging from 0.2–0.3mg/kg found only one case of psycho-
                                                                             93
          dissociative dose range). While this amount slightly exceeds    logical disturbances.  Another study  evaluating the service
          0.4mg/kg for a 70-kg service member (corresponding to   members’ ability to perform military tasks when given 50mg
          0.42mg/kg), we believe this is a reasonable risk based upon   IM ketamine demonstrated that patients were aware of their
          the preponderance of service members requiring higher doses.   impairment and performed tasks slower when compared to
                                                                               94
          LDK remains the ideal initial dosing strategy to minimize side   morphine  (10mg  IM).   The  mid-range  dosing  of  ketamine,
          effects. Providers can redose and titrate this ketamine dose to   0.5–0.8mg/kg IV, is used by recreational users and for ket-
          achieve the desired analgesic effect while maintaining safety.  amine-assisted psychotherapy as it begins to produce euphoria
                                                             and hallucinations. When used in patients in pain, this dose
          Intranasal (IN) Dosing Considerations              range can produce disruptive hallucinations as the patient is
          The intranasal (IN) route for administering medications is a   not yet fully dissociated. At higher doses of 0.8–2mg/kg IV,
          desirable method for several reasons including direct drug de-  patients become dissociated from their environment gen-
          livery to the central nervous system and bypassing the time and   erally with preserved cardiac and respiratory status. This is
          skill for IV placement. An ED study comparing IN ketamine   most likely due to the disruption of the thalamocortical and
                                                                         48
          via atomization of a 50mg/mL solution dosed at 0.75mg/kg   limbic systems.  These effects last 20–30 minutes and vary
          found similar pain control in migraine patients when com-  by patient. While this dissociation may appear traumatic in
                                 84
          pared to standard protocols.  Atomizers help achieve max-  itself, a prehospital study using ketamine in severe agitation
                               85
          imum efficacy in delivery.   Atomizers are a small tool that   noted there was no increased incidence of required psychiatric
          can be added to the tip of a syringe and improve drug deliv-  evaluations or admissions in the patients administered various
          ery by creating smaller particles that absorb better, enhancing   doses of prehospital ketamine. 95
          systemic drug delivery and reducing leak and loss of medica-
          tion.  Notably, the patient must be cooperative patient and   Emergence Phenomenon and
              86
          without dried blood or dirt in the nasal cavity for this method   Incomplete Dissociation
          of administration to work. IN dosing has to date proven to be   The unpleasant sensations associated with incomplete disso-
          difficult to sustain with limited effectiveness in the deployed   ciation  and emergence  phenomenon are  often  confused and
          setting. 31                                        poorly defined. Incomplete dissociation and emergence phe-
                                                             nomena are very similar in terms of signs and symptoms,
          Dosing Considerations                              though incomplete dissociation tends to occur with the mid-
          Ideally,  casualties should  receive  one  drug  at  the POI.  This   range dosing of ketamine (0.5–0.9mg/kg IV) while emergence
          simplistic approach is optimal for better patient care and miti-  reactions occur as a patient resurfaces after full dissociation.
          gates the risk of polypharmacy and adverse events in a chaotic   Descriptions of emergence phenomenon have included feelings
          environment and prior to monitor placement.        of unreality, “spaced out,” euphoria, disconnectedness, rest-
                                                             lessness, agitation, crying, inconsolability, hallucination, vivid
          Ketamine has an excellent safety profile. However, as previ-  dreaming, floating, and delirium. 93,96,97  A single double-blind
          ously discussed, adverse events may increase with higher dose   study comparing morphine to ketamine (0.5mg/kg) for pa-
          and rate of administration. To mitigate any adverse events, the   tients with long bone fractures demonstrated that ketamine
          CoTCCC recommends that responders administer ketamine in   was effective but also had an emergence phenomenon in 9.5%
          more frequent smaller doses versus one larger dose.  of the patients. 98

          Ketamine Side Effects and Adverse Events           There is no available data on the incidence of emergence phe-
          The effects of ketamine are rate and dose dependent. 87,88  Rap-  nomenon on the battlefield. Fisher et al. describe incomplete
          idly pushing ketamine can induce unpleasant sensations, as   dissociation in an operational setting but without emergence
          well as impact the risk of apnea, nausea, vomiting, and diz-  phenomenon issues, implying that true emergence phenome-
          ziness. Nausea and vomiting are common side effects. While   non is uncommon in this setting.  Hence, the initial treatment
                                                                                      99
          generally considered cardioprotective, IV ketamine has been   of unpleasant sensations should be redosing of ketamine. If re-
          reported  to  cause  hypotension  when  pushed  too  rapidly  or   dosing ketamine is not possible or if responders suspect a true
          when medication errors result in a large overdose of IV ket-  emergence reaction, the CoTCCC recommends administering
          amine. 90,91  Similarly, a recent observational analysis from the   a benzodiazepine such as midazolam.  However, it is of the
                                                                                          100
          National Emergency Airway Registry (NEAR) found a greater   utmost importance to emphasize that responders should not
          risk of periintubation hypotension with ketamine as compared   routinely administer benzodiazepines together with ketamine
          to etomidate, though most of these patients received ketamine   because of their respiratory depressant effect. A retrospective
          in doses exceeding the low dose range.  These observational   study from Iraq reported that paramedics gave 5mg diazepam
                                         21
                                                                                                            50
          findings require further study by randomized trial designs, but   to 32% (n = 713) of the patients who received ketamine.
          responders should understand the uncommon but nevertheless   It appears that many of these doses were prophylactic and
          possible outcome of ketamine administration reducing blood   may have affected vital signs, however the authors do not
          pressure, perhaps due to alleviation of catecholamine release   report the changes in vitals for that cohort. Additionally, a
          associated with pain.                              review of 35 studies with 8,282 pediatric patients found the


          158  |  JSOM   Volume 22, Edition 2 / Summer 2022
   157   158   159   160   161   162   163   164   165   166   167